Advertisement

Taurine 2 pp 641-650 | Cite as

Taurine

Past, Present, and Future
  • Ryan J. Huxtable
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 403)

Abstract

A major problem facing biomedical science in the Western nations is the loss of faith by the public in the conventional health care system. This has given rise to a pluralistic attitude in which the public simultaneously patronizes conventional health care delivery while also using “natural” remedies, over-the-counter preparations, herbs, vitamin and mineral supplements, and turning for treatment to those who practice any of a wide variety of so-called natural, holistic or traditional medicines. The latter may be eclectically derived from a variety of cultures, mixing elements of Traditional Chinese Medicine, Ayur-Vedic preparations, Japanese kampo and various European folk remedies. Accompanying this, at least in the U.S.A., has been the development of a common belief, articulated in a variety of ways, that being healthy is not so much a natural state, but one that must be maintained and protected by vigorous and continual intervention.

Keywords

Sulfur Metabolism Sulfur Amino Acid Pyrrolizidine Alkaloid Taurine Content Cardiomyopathic Hamster 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Azari, J., Brumbaugh, P., and Huxtable, R.J. 1980, Prophylaxis by taurine in the hearts of cardiomyopathic hamsters, J.Mol.Cell.Cardiol. 12:1353–1366.CrossRefGoogle Scholar
  2. 2.
    Azuma, J., Hasagawa, H., Awata, N., Sawamura, A., Harada, H., Ogura, K., Ohta, H., Yamauchi, K., and Kishimoto, S. 1983, Taurine for treatment of congestive heart failure in humans, in: “Sulfur Amino Acids: Biochemical and Clinical Aspects”, Kuriyama, K., Huxtable, R.J. and Iwata, H. eds., A. R. Liss, New York, pp. 61–72.Google Scholar
  3. 3.
    Azuma, J., Sawamura, A., Awata, N., Ohta, H., Hamaguchi, T., Harada, H., Takihara, K., Hasegawa, H., Yamagami, T., Ishiyama, T., Iwata, H., and Kishimoto, S. 1985, Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial, Clin.Cardiol. 8:276–282.CrossRefGoogle Scholar
  4. 4.
    Azuma, J., Takahisa, K., Awata, N., Ohta, H., Sawamura, A., Harada, H., and Kishimoto, S. 1984, Beneficial effect of taurine on congestive heart failure induced by chronic aortic regurgitation in rabbits, Res.Comm.Chem.Pathol.Pharmacol. 45:261–270.Google Scholar
  5. 5.
    Banks, M.A., Porter, D.W., Martin, W.G., and Castranova, V. 1991, Ozone-induced lipid peroxidation and membrane leakage in isolated rat alveolar macrophages: Protective effects of taurine, J.Nutr.Biochem. 2:308–313.CrossRefGoogle Scholar
  6. 6.
    Chauvin, P., Dillon, J.-C., Moren, A., Talbak, S., and Barakaev, S. 1993, Heliotrope poisoning in Tadjikistan, Lancet, 341:1663CrossRefGoogle Scholar
  7. 7.
    Cooper, M.W. and Lombardini, J.B. 1982, Elevated blood taurine levels after myocardial infarction or cardiovascular surgery: is there any significance? in: “Taurine in Nutrition and Neurology”, Huxtable, R.J. and Pasantes-Morales, H. eds., Plenum Press, New York, pp. 191–206.CrossRefGoogle Scholar
  8. 8.
    Desai, T.K., Maliakkal, J., Kinzie, J.L., Ehrinpreis, M.N., Luk, G.D., and Cejka, J. 1992, Taurine deficiency after intensive chemotherapy and/or radiation, Am.J.Clin.Nutr. 55:708–711.Google Scholar
  9. 9.
    Dilley, J.V. 1972, The origin of urinary taurine excretion during chronic radiation injury, Radiation Res. 50:191–196.CrossRefGoogle Scholar
  10. 10.
    Dokshina, G.A., Yartsev, E.I., Kolesnikov, Y.A., and Kostesha, N.Y 1974, Influence of taurine on the recovery of tissue respiration and oxidative phosphorylation in liver mitochondria in irradiated rats, Radiology, 14:44–48.Google Scholar
  11. 11.
    Eley, D.W., Lake, N., and ter Keurs, H.E.D.J. 1994, Taurine depletion and excitation-contraction coupling in rat myocardium, Circ.Res. 74:1210–1219.CrossRefGoogle Scholar
  12. 12.
    Elizarova, E.P., Orlova, T.R., and Medvedeva, N.V. 1993, Effects on heart membranes after taurine treatment in rabbits with congestive heart failure, Arzneimittelforschung, 43:308–312.Google Scholar
  13. 13.
    Ewoane, C., Portemer, C., Bernard, P., and Chatagner, F. 1982, Effect of in vivo irradiation of the rat on the taurine concentration of the heart, Experientia, 38:1033CrossRefGoogle Scholar
  14. 14.
    Fox, D.W., Hart, M.C., Bergeson, P.S., Jarrett, P.B., Stillman, A.E., and Huxtable, R.J. 1978, Pyrrolizidine (Senecio) intoxication mimicking Reye’s syndrome, J.Pediatr. 93:980–982.CrossRefGoogle Scholar
  15. 15.
    Franconi, F., Giotti, A., Manzini, S., Martini, F., Stendardi, I., and Zilletti, L. 1982, Observations on the action of taurine at arterial and cardiac levels, in: “Taurine in Nutrition and Neurology”, Huxtable, R.J. and Pasantes-Morales, H. eds., Plenum Press, New York, pp. 181–190.CrossRefGoogle Scholar
  16. 16.
    Franconi, F., Martini, F., Stendardi, I., Matucci, R., Zilletti, L., and Giotti, A. 1982, Effect of taurine on calcium levels and contractility in guinea pig ventricular strips, Biochem.Pharmacol. 31:3181–3186.CrossRefGoogle Scholar
  17. 17.
    Franconi, F., Stendardi, I., Martini, F., Zilletti, L., and Giotti, A. 1982, Interaction between organic calcium-channel blockers and taurine in vitro and in vivo, J.Pharm.Pharmacol. 34:329–330.CrossRefGoogle Scholar
  18. 18.
    Franconi, F., Stendardi, I., Matucci, R., Failli, P., Bennardini, F., Antonini, G., and Giotti, A. 1984, Inotropic effect of taurine in guinea-pig ventricular strips, Eur. J.Pharmacol. 102:511–514.CrossRefGoogle Scholar
  19. 19.
    Gaull, G.E., Rassin, D.K., Raiha, N.C.R., and Heinonen, K. 1977, Milk protein quantity and quality in low birth weight infants. III. Effects on sulfur-containing amino acids in plasma and urine. J.Pediatr. 90:348–355.CrossRefGoogle Scholar
  20. 20.
    Geiss, K.-R., Jester, I., Falke, W., Hamm, M., and Waag, K.-L. 1994, The effects of a taurine-containing drink on performance in 10 endurance-athletes, Amino Acids, 7:45–56.CrossRefGoogle Scholar
  21. 21.
    Goeger, D.E., Cheeke, P.R., Schmitz, J.A., and Buhler, D.R. 1982, Effect of feeding milk from goats fed tansy ragwort (Senecio jacobaea) to rats and calves, Am.J. Vet.Res. 43:1631–1633.Google Scholar
  22. 22.
    Gordon, R.E., Shaker, A.A., and Solano, D.F. 1986, Taurine protects hamster bronchioles from acute NO2-induced alterations, Am.J.Pathol. 125:585–600.Google Scholar
  23. 23.
    Gruener, R., Bryant, H., Markovitz, D., Huxtable, R.J., and Bressler, R. 1976, Ionic actions of taurine on nerve and muscle membranes: electrophysiologic studies, in: “Taurine”, Huxtable, R.J. and Barbeau, A. eds., Raven Press, New York, pp. 225–242.Google Scholar
  24. 24.
    Huxtable, R.J. 1980, Herbal teas and toxins: novel aspects of pyrrolizidine poisoning in the United States, Perspect.Biol.Med. 24:1–14.Google Scholar
  25. 25.
    Huxtable, R.J. 1989, Taurine in the central nervous system and the mammalian actions of taurine, Prog.Neurobiol. 32:471–533.CrossRefGoogle Scholar
  26. 26.
    Huxtable, R.J. 1989, Human health implications of pyrrolizidine alkaloids and herbs containing them, in: “Toxicants of Plant Origin, Vol I: Alkaloids”, Cheeke, PR. ed., CRC Press, Boca Raton, Florida, pp. 41–86.Google Scholar
  27. 27.
    Huxtable, R.J. 1990, The harmful potential of herbal and other plant products, Drug Safety, 5 (Suppl. 1):126–136.CrossRefGoogle Scholar
  28. 28.
    Huxtable, R.J. 1992, Physiological actions of taurine, Physiol.Rev. 72:101–163.Google Scholar
  29. 29.
    Huxtable, R.J. 1992, The toxicology of alkaloids in foods and herbs, in: “Handbook of Natural Toxins: Vol. 7 Food Poisoning”, Tu, AT. ed., Marcel Dekker, New York, pp. 237–262.Google Scholar
  30. 30.
    Huxtable, R.J., Crosswell, S., and Parker, D. 1989, Phospholipid composition and taurine content of synaptosomes in developing rat brain, Neurochem.International, 15:233–238.CrossRefGoogle Scholar
  31. 31.
    Huxtable, R.J., Luthy, J., and Zweifel, V. 1986, Comfrey pepsin preparations-a warning, N.Engl.J.Med. 315:1095Google Scholar
  32. 32.
    Irving, C.S., Marks, L., Klein, P.D., Foster, N., Gadde, P.L., Chase, T.N., and Samuel, D. 1986, New evidence for taurine biosynthesis in man obtained from 18O2 inhalation studies, Life Sci. 38:491–496.CrossRefGoogle Scholar
  33. 33.
    Izumi, K., Nagata, R., Motoya, T., Yamashita, J., Hirokane, T., Nagata, T., Satoh, Y., Sawada, Y., Ishibashi, M., Yoshida, H., and Fukuda, T. 1989, Preventive effect of taurine against acute paraquat intoxication in beagles, Jpn.J.Pharmacol. 50:229–233.CrossRefGoogle Scholar
  34. 34.
    Johnson, A.E. 1976, Changes in calves and rats consuming milk from cows fed chronic lethal doses of Senecio jacobaea (tansy ragwort), Am.J. Vet.Res. 37:107–110.Google Scholar
  35. 35.
    Khatter, J.C., Soni, P.L., Hoeschen, R.J., Alto, L.E., and Dhalla, N.S. 1981, Subcellular effects of taurine on guinea pig heart, in: “The Effects of Taurine on Excitable Tissues”, Schaffer, S.W., Baskin, S.I. and Kocsis, J.J. eds., Spectrum Publications, New York, pp. 281–294.CrossRefGoogle Scholar
  36. 36.
    Kramer, J.H., Chovan, J.P., and Schaffer, S.W. 1981, Effect of taurine on calcium paradox and ischemic heart failure, Am.J.Physiol. 240:H238–H246.Google Scholar
  37. 37.
    Kupryszewski, G., Ragnarsson, U., Rolka, K., and Wilusz, T. 1985, Lowering of liver acetaldehyde but not ethanol concentrations by pretreatment with taurine in ethanol-loaded rats, Experientia, 41:1421CrossRefGoogle Scholar
  38. 38.
    Lafranconi, W.M., Ohkuma, S., and Huxtable, R.J. 1985, Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline, Toxicon, 23:983–992.CrossRefGoogle Scholar
  39. 39.
    Lake, N. 1992, Effects of taurine deficiency on arrhythmogenesis and excitation-contraction coupling in cardiac tissue, Adv.Exp.Med.Biol. 315:173–179.CrossRefGoogle Scholar
  40. 40.
    Lake, N. 1993, Loss of cardiac myofibrils: Mechanism of contractile deficits induced by taurine deficiency, Am.J.Physiol.Heart Circ.Physiol. 264:H1323–H1326.Google Scholar
  41. 41.
    Lake, N., Eley, D.W., and ter Keurs, H.E.D.J. 1991, The effects of taurine depletion on excitation-contraction coupling in rat cardiac trabeculae, Biophys.J. 59:64aGoogle Scholar
  42. 42.
    Lehnert, B.E., Archuleta, D.C., Ellis, T., Session, W.S., Lehnert, N.M., Gurley, L.R., and Stavert, D.M. 1994, Lung injury following exposure of rats to relatively high mass concentrations of nitrogen dioxide, Toxicology, 89:239–277.CrossRefGoogle Scholar
  43. 43.
    Lleu, P.-L. and Huxtable, R.J. 1992, Phospholipid methylation and taurine content of synaptosomes from cerebral cortex of developing rat, Neurochem.International, 21:109–118.CrossRefGoogle Scholar
  44. 44.
    Lombardini, J.B. and Bricker, D.L. 1981, Effects of cardiovascular surgery on blood concentrations of taurine and amino acids, Proc.Soc.Exp.Biol.Med. 167:498–505.CrossRefGoogle Scholar
  45. 45.
    Mattocks, A.R., Croswell, S., Jukes, R., and Huxtable, R.J. 1991, Identity of a biliary metabolite formed from monocrotaline in isolated, perfused rat liver, Toxicon, 29:409–415.CrossRefGoogle Scholar
  46. 46.
    Mayer, F. and Lüthy, J. 1993, Heliotrope poisoning in Tadjikistan, Lancet, 342:246–247.CrossRefGoogle Scholar
  47. 47.
    Moise, N.S., Pacioretty, L.M., Kallfelz, F.A., Stipanuk, M.H., King, J.M., and Gilmour, R.F., Jr. 1991, Dietary taurine deficiency and dilated cardiomyopathy in the fox, Am.Heart J. 121:541–547.CrossRefGoogle Scholar
  48. 48.
    Nakashima, T., Takino, T., and Kuriyama, K. 1983, Therapeutic and prophylactic effects of taurine administration on experimental liver injury, in: “Sulfur Amino Acids: Biochemical and Clinical Aspects”, Kuriyama, K., Huxtable, R.J. and Iwata, H. eds., Alan R. Liss, Inc., New York, pp. 449–460.Google Scholar
  49. 49.
    Pion, P.D., Kittleson, M.D., Rogers, Q.R., and Morris, J.G. 1987, Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy, Science, 237:764–768.CrossRefGoogle Scholar
  50. 50.
    Raghavan, K.G. and Nadkarni, G.B. 1970, Formation and excretion of taurine in X-irradiated rats, InU.Radiat.Biol. 18(1):41–49.CrossRefGoogle Scholar
  51. 51.
    Rassin, D.K. 1982, Taurine, cysteine sulfinic acid decarboxylase and glutamic acid in brain, in: “Taurine in Nutrition and Neurology”, Huxtable, R.J. and Pasantes-Morales, H. eds., Plenum Press, New York, pp. 257–268.CrossRefGoogle Scholar
  52. 52.
    Schaffer, S.W., Chovan, J., Kramer, J., and Kulakowski, E. 1981, The role of taurine receptors in the heart, in: “The effects of taurine on excitable tissues”, Schaffer, S.W., Baskin, S.I. and Kocsis, J.J. eds. Spectrum Publications, New York, pp. 261–279.CrossRefGoogle Scholar
  53. 53.
    Schoental, R. 1959, Liver lesions in young rats suckled by mothers treated with the pyrrolizidine (Senecio) alkaloids, lasiocarpine, and retrorsine, J.Path.Bact. 77:485–495.CrossRefGoogle Scholar
  54. 54.
    Stillman, A.E., Huxtable, R., Consroe, P., Kohnen, P., and Smith, S. 1977, Hepatic veno-occlusive disease due to pyrrolizidine poisoning in Arizona, Gastroenterology, 73:349–352.Google Scholar
  55. 55.
    Sturman, J.A. and Gaull, G.E. 1976, Taurine in the brain and liver of the developing human and rhesus monkey, in: “Taurine”, Huxtable, R. and Barbeau, A. eds., Raven Press, New York, pp. 73–84.Google Scholar
  56. 56.
    Suleiman, M.-S., Fernando, H.C., Dihmis, W.C., Hutter, J.A., and Chapman, R.A. 1993, A loss of taurine and other amino acids from ventricles of patients undergoing bypass surgery, Br.Heart J. 69:241–245.CrossRefGoogle Scholar
  57. 57.
    Turner, F.P. and Blum, V.G. 1964, The urinary excretion of free taurine in acute and chronic disease, following surgical trauma, and in patients with acute alcoholism, J.Surg.Res. 4:423–431.CrossRefGoogle Scholar
  58. 58.
    United Nations Environment Programme, International Labour Organization, and World Health Organization 1988, “Environmental Health Criteria 80: Pyrrolizidine Alkaloids”, World Health Organization, Geneva.Google Scholar
  59. 59.
    Venkatesan, N. and Chandrakasan, G. 1994, In vivo administration of taurine and niacin modulate cyclophosphamide-induced lung injury, Eur.J.Pharmacol.Environ. Toxicol.Pharmacol. 292:75–80.CrossRefGoogle Scholar
  60. 60.
    Wang, Q., Giri, S.N., Hyde, D.M., and Li, C. 1991, Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin, Biochem.Pharmacol. 42:1115–1122.CrossRefGoogle Scholar
  61. 61.
    Wang, Q., Hollinger, M.A., and Giri, S.N. 1992, Attenuation of amiodarone-induced lung fibrosis and phospholipidosis in hamsters by taurine and/or niacin treatment, J.Pharmacol.Exp.Ther. 262:127–132.Google Scholar
  62. 62.
    Watson, G.M. 1962, The origin of taurine excreted in the urine after whole body irradiation, Inter. J.Rad.Biol. 5:79–83.CrossRefGoogle Scholar
  63. 63.
    Welty, J.D. and McBroom, M.J. 1985, Effects of verapamil and taurine administration on heart taurine and calcium in BIO 14.6 cardiomyopathic hamsters, Res.Comm.Chem.Pathol.Pharmacol. 49:141–144.Google Scholar
  64. 64.
    White, I.N.H. 1976, The role of liver glutathione in the acute toxicity of retrorsine to rats, Chem.-Biol.Interact. 13:333–342.CrossRefGoogle Scholar
  65. 65.
    Yan, C.C. and Huxtable, R.J. 1995, Effects of the pyrrolizidine alkaloid, retrorsine, on sulfur metabolism in the liver, Proc. Western Pharmacol.Soc. 38:37–40.Google Scholar
  66. 66.
    Yan, C.C. and Huxtable, R.J. 1995, Effect of the pyrrolizidine alkaloid, monocrotaline, on bile composition of the isolated, perfused rat liver, Life Sci. 57:617–626.CrossRefGoogle Scholar
  67. 67.
    Yan, C.C. and Huxtable, R.J. 1996, Effects of the pyrrolizidine alkaloid, monocrotaline, on glutathione metabolism in the rat, Biochem.Pharmacol. 51:375–379.CrossRefGoogle Scholar
  68. 68.
    Yan, C.C. and Huxtable, R.J. 1995, The effect of the pyrrolizidine alkaloids, monocrotaline and trichodesmine, on hepatic glutathione synthesis in the rat, Toxicon, 33:627–634.CrossRefGoogle Scholar
  69. 69.
    Yan, C.C. and Huxtable, R.J. 1995, The effect of the pyrrolizidine alkaloids, monocrotaline and trichodesmine, on tissue pyrrole binding and glutathione metabolism in the rat, Toxicon, 33:627–634.CrossRefGoogle Scholar
  70. 70.
    Yan, C.C. and Huxtable, R.J. 1995, Effects of taurine and guanidinoethane sulfonate on right ventricular hypertrophy induced by the pyrrolizidine alkaloid, monocrotaline, Biochem.Pharmacol. 51:321–329.CrossRefGoogle Scholar
  71. 71.
    Yan, C.C. and Huxtable, R.J. 1996, Effect of pyrrolizidine alkaloids on taurine and sulfur metabolism in the rat liver, in: “Taurine: Basic and Clinical Aspects”, Huxtable, R.J., Azuma, J., Nakagawa, M., Kuriyama, K. and Baba, A. eds., Plenum, New YorkGoogle Scholar
  72. 72.
    Yan, C.C. and Huxtable, R.J. 1996, Effect of taurine on toxicity of the pyrrolizidine alkaloid, monocrotaline, in rats, in: “Taurine: Basic and Clinical Aspects”, Huxtable, R.J., Azuma, J., Nakagawa, M., Kuriyama, K. and Baba, A. eds., Plenum, New YorkGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Ryan J. Huxtable
    • 1
  1. 1.Department of Pharmacology College of MedicineUniversity of ArizonaTucsonUSA

Personalised recommendations